Cargando…

A Vancomycin HPLC Assay for Use in Gut Microbiome Research

The human microbiome project has revolutionized our understanding of the interaction between commensal microbes and human health. By far, the biggest perturbation of the microbiome involves use of broad-spectrum antibiotics excreted in the gut. Thus, pharmacodynamics of microbiome changes in relatio...

Descripción completa

Detalles Bibliográficos
Autores principales:	Hu, Chenlin, Beyda, Nicholas D., Garey, Kevin W.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	American Society for Microbiology 2022
Materias:	Research Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9241942/ https://www.ncbi.nlm.nih.gov/pubmed/35536037 http://dx.doi.org/10.1128/spectrum.01688-21

Ejemplares similares

620. Pharmacokinetic-Pharmacodynamic Analysis of Oral Vancomycin and Gut Microbiome Changes in Healthy Volunteers: an Exploratory Study
por: Jo, Jinhee, et al.
Publicado: (2022)

382. Virulence in Candida glabrata Is Not Attenuated by FKS Mutations but Associated With the Frequency of Cells With Distinct Morphology
por: Hu, Chenlin, et al.
Publicado: (2018)

381. Morphologic Changes Associated With Echinocandin Tolerance Enhance Immunoevasion of Candida glabrata
por: Hu, Chenlin, et al.
Publicado: (2018)

43. A Pharmacoepidemiologic Evaluation of Echinocandin Use
por: Jo, Jinhee, et al.
Publicado: (2020)

Effect of Vancomycin on the Gut Microbiome and Plasma Concentrations of Gut-Derived Uremic Solutes
por: Nazzal, Lama, et al.
Publicado: (2021)

Clumping Morphology Influences Virulence Uncoupled from Echinocandin Resistance in Candida glabrata
por: Hu, Chenlin, et al.
Publicado: (2022)

2581. An Invertebrate Model to Study Gut Microbiome Dysbiosis
por: Alnezary, Faris S, et al.
Publicado: (2019)

Effects of vancomycin‐induced gut microbiome alteration on the pharmacodynamics of metformin in healthy male subjects
por: Kim, Eunwoo, et al.
Publicado: (2021)

A simple and validated HPLC method for vancomycin assay in plasma samples: the necessity of TDM center development in Southern Iran
por: Ghasemiyeh, Parisa, et al.
Publicado: (2020)

Genetic Mechanisms of Vancomycin Resistance in Clostridioides difficile: A Systematic Review
por: Eubank, Taryn A., et al.
Publicado: (2022)

Microbiome-mediated fructose depletion restricts murine gut colonization by vancomycin-resistant Enterococcus
por: Isaac, Sandrine, et al.
Publicado: (2022)

Simultaneous and Direct Determination of Vancomycin and Cephalexin in Human Plasma by Using HPLC-DAD Coupled with Second-Order Calibration Algorithms
por: Hu, Le-Qian, et al.
Publicado: (2012)

157. A Multicenter, Mixed-Method Evaluation of Delayed Hospital Discharge in Patients with Invasive Candidiasis Receiving Echinocandins
por: Jo, Jinhee, et al.
Publicado: (2021)

Microbe-Metabolite Associations Linked to the Rebounding Murine Gut Microbiome Postcolonization with Vancomycin-Resistant Enterococcus faecium
por: Mu, Andre, et al.
Publicado: (2020)

A pilot study to assess bacterial and toxin reduction in patients with Clostridium difficile infection given fidaxomicin or vancomycin
por: Thabit, Abrar K., et al.
Publicado: (2016)

380. A molecular epidemiological exploration of reduced vancomycin susceptibility in Clostridioides difficile
por: Eubank, Taryn A, et al.
Publicado: (2022)

668. Quality of Life Changes in Patients with Clostridium difficile Infection (CDI): A Randomized, Double-Blind Trial of Ridinilazole (RDZ) Compared with Vancomycin (VAN)
por: Paul, Sumita, et al.
Publicado: (2019)

LB7. A Randomized, Blinded, Placebo- and Vancomycin-Controlled, First-In-Human (FIH) Study of the Safety, Pharmacokinetics (PK), and Fecal Microbiome Effects of ACX-362E, a Novel Anti-Clostridial DNA Polymerase IIIC (polIIIC) Inhibitor
por: Garey, Kevin W, et al.
Publicado: (2019)

Development and validation of an HPLC method for the determination of vancomycin in human plasma and its comparison with an immunoassay (PETINIA)
por: Usman, Muhammad, et al.
Publicado: (2016)

The Western Dietary Pattern Combined with Vancomycin-Mediated Changes to the Gut Microbiome Exacerbates Colitis Severity and Colon Tumorigenesis
por: Aardema, Niklas D., et al.
Publicado: (2021)

Vancomycin-resistance gene cluster, vanC, in the gut microbiome of acute leukemia patients undergoing intensive chemotherapy
por: Rashidi, Armin, et al.
Publicado: (2019)

Integrating gut microbiome and host immune markers to understand the pathogenesis of Clostridioides difficile infection
por: Ke, Shanlin, et al.
Publicado: (2021)

Protection of gut microbiome from antibiotics: development of a vancomycin-specific adsorbent with high adsorption capacity
por: YUZURIHA, Kazuki, et al.
Publicado: (2020)

1066. Adjuvant β-Lactam Therapy Combined with Vancomycin for Methicillin-Resistant Staphylococcus aureus (MRSA) Bacteremia: Does β-Lactam class Matter?
por: Dilworth, Thomas J, et al.
Publicado: (2018)

2164. Resistome patterns associated with vancomycin non-susceptibility in clinical Clostridioides difficile isolates
por: Eubank, Taryn A, et al.
Publicado: (2023)

Stability-Indicating HPLC Method for Posaconazole Bulk Assay
por: Garcia, Cássia V., et al.
Publicado: (2012)

741. Antifungal Resistant Candida glabrata Are Most Commonly Colonized in Clostridioides difficile Infection (CDI) Patient Guts in Texas
por: Begum, Khurshida, et al.
Publicado: (2020)

The leaky gut and the gut microbiome in sepsis – targets in research and treatment
por: Chancharoenthana, Wiwat, et al.
Publicado: (2023)

Development of the invasive candidiasis discharge [I Can discharge] model: a mixed methods analysis
por: Jo, Jinhee, et al.
Publicado: (2022)

Gut Microbiota Predict Enterococcus Expansion but Not Vancomycin-Resistant Enterococcus Acquisition
por: Chanderraj, Rishi, et al.
Publicado: (2020)

377. High Resistance and Mortality Rates in Patients With Ventricular Assist Device (VAD)-Associated Candidemia: A Need for Alternative Antifungal Strategies
por: Fong, Gary, et al.
Publicado: (2018)

Challenges and opportunities of strain diversity in gut microbiome research
por: Anderson, Benjamin D., et al.
Publicado: (2023)

Research Progress of the Gut Microbiome in Hybrid Fish
por: Cui, Xinyuan, et al.
Publicado: (2022)

Application of emerging technologies for gut microbiome research
por: Kwa, Wit Thun, et al.
Publicado: (2023)

277. A Functional OMICs Evaluation of Omadacycline to Understand Anti-Clostridioides difficile Protective Effects
por: Jo, Jinhee, et al.
Publicado: (2023)

521. Investigating the Gram-Positive Selective Spectrum of Ibezapolstat, a First-in-Class DNA Polymerase IIIC (Pol IIIC) Inhibitor
por: Jahangir Alam, M, et al.
Publicado: (2022)

Accelerating Gut Microbiome Research with Robust Sample Collection
por: Zreloff, Zoe J., et al.
Publicado: (2023)

Stability-Indicating HPLC Assay for Determination of Idebenone in Pharmaceutical Forms
por: Kombath, Sonoube, et al.
Publicado: (2015)

Efficacy, Safety, Pharmacokinetics, and Microbiome Changes of Ibezapolstat in Adults with Clostridioides difficile Infection: A Phase 2a Multicenter Clinical Trial( )
por: Garey, Kevin W, et al.
Publicado: (2022)

Efficacy of Bezlotoxumab in Participants Receiving Metronidazole, Vancomycin, or Fidaxomicin for Treatment of Clostridioides (Clostridium) difficile Infection
por: Dubberke, Erik R, et al.
Publicado: (2020)

Cannot write session to /tmp/vufind_sessions/sess_kbe1ghk4h215n9gk8ncvfi7vb5